Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
American Journal of Hematology
|
September 4, 2020
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3)
Koji Sasaki, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, et al.
Leukemia Research
|
October 26, 2024
A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure
Kelly S Chien, Juan Jose Rodriguez-Sevilla, Yesid Alvarado, et al.
Blood Advances
|
March 21, 2024
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, et al.
American Journal of Hematology
|
July 29, 2023
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure
Samuel Urrutia, Kelly S Chien, Ziyi Li, et al.
Cancer
|
June 19, 2024
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage
Georgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, et al.
Cancer
|
December 2, 2022
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia
Alexandre Bazinet, Faezeh Darbaniyan, Tapan M Kadia, et al.
Leukemia Research
|
August 23, 2024
Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis
David McCall, Tareq Abuasab, Juan Jose Rodriguez-Sevilla, et al.
Blood
|
July 13, 2023
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia
Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, et al.
Hematological Oncology
|
August 29, 2018
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome
Christopher B Benton, Kelly S Chien, Ayalew Tefferi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2025
Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib
Kelly S Chien, Sanam Loghavi, Koji Sasaki, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
American Journal of Hematology
|
September 4, 2020
Natural history of newly diagnosed myelodysplastic syndrome with isolated inv(3)/t(3;3)
Koji Sasaki, Guillermo Montalban-Bravo, Rashmi Kanagal-Shamanna, et al.
Leukemia Research
|
October 26, 2024
A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure
Kelly S Chien, Juan Jose Rodriguez-Sevilla, Yesid Alvarado, et al.
Blood Advances
|
March 21, 2024
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, et al.
American Journal of Hematology
|
July 29, 2023
Performance of IPSS-M in patients with myelodysplastic syndrome after hypomethylating agent failure
Samuel Urrutia, Kelly S Chien, Ziyi Li, et al.
Cancer
|
June 19, 2024
NPM1-mutated myeloid neoplasms are a unique entity not defined by bone marrow blast percentage
Georgina Gener-Ricos, Alex Bataller, Juan Jose Rodriguez-Sevilla, et al.
Cancer
|
December 2, 2022
A retrospective study of cladribine and low-dose cytarabine-based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia
Alexandre Bazinet, Faezeh Darbaniyan, Tapan M Kadia, et al.
Leukemia Research
|
August 23, 2024
Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis
David McCall, Tareq Abuasab, Juan Jose Rodriguez-Sevilla, et al.
Blood
|
July 13, 2023
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia
Jayastu Senapati, Samuel Urrutia, Sanam Loghavi, et al.
Hematological Oncology
|
August 29, 2018
Safety and tolerability of lurbinectedin (PM01183) in patients with acute myeloid leukemia and myelodysplastic syndrome
Christopher B Benton, Kelly S Chien, Ayalew Tefferi, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 30, 2025
Outcomes of Patients With IDH1-Mutated Myeloid Neoplasms Treated With Olutasidenib
Kelly S Chien, Sanam Loghavi, Koji Sasaki, et al.
Page
of 5